Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 449-455

  Vuola, Jenni M ^a,c   Keating, Sheila ^a   Webster, Daniel P ^a   Berthoud, Tamara ^a   Dunachie, Susanna ^a   Gilbert, Sarah C ^b   Hill, Adrian V S ^a,b,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; ERYTHROCYTE ANTIGEN; GAMMA INTERFERON; LIVE VACCINE; NAKED DNA; PRIMER DNA; THROMBOSPONDIN; VIRUS VECTOR;

ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; DNA VECTOR; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOGENICITY; MALARIA FALCIPARUM; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; T LYMPHOCYTE;

EID: 10844264174     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.449     Document Type: Article

References (23)

1. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 19:1745.
2. Donnelly, J., K. Berry, and J. B. Ulmer. 2003. Technical and regulatory hurdles for DNA vaccines. Int. J. Parasitol. 33:457.
3. Bonnet, M. C., J. Tartaglia, F. Verdier, P. Kourilsky, A. Lindberg, M. Klein, and P. Moingeon. 2000. Recombinant viruses as a tool for therapeutic vaccination against human cancers. Immunol. Lett. 74:11.
4. + T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. USA 90:5214.
5. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4:397.
6. Sedegah, M., T. R. Jones, M. Kaur, R. Hedstrom, P. Hobart, J. A. Tine, and S. L. Hoffman. 1998. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA 95:7648.
7. Schneider, J., J. A. M. Langermans, S. C. Gilbert, T. J. Blanchard, S. Twigg, S. Naitza, C. M. Hannan, M. Aidoo, A. Crisanti, K. J. Robson, et al. 2001. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees. Vaccine 19:4595.
8. Rogers, W. O., J. K. Baird, A. Kumar, J. A. Tine, W. Weiss, J. C. Aguiar, K. Gowda, R. Gwadz, S. Kumar, M. Gold, and S. L. Hoffman. 2001. Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect. Immun. 69:5565.
9. Kent, S. J., A. Zhao, S. J. Best, J. D. Chandler, D. B. Boyle, and I. A. Ramshaw. 1998. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72:10180.
10. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, et al. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69.
11. Pastoret, P.-P., and A. Vanderplasschen. 2003. Poxviruses as vaccine vectors. Comp. Immunol. Microbiol. Infect. Dis. 26:343.
12. Moorthy, V. S., S. McConkey, M. Roberts, P. Goulard, N. Arulanantham, P. Degano, J. Schneider, C. Hannan, M. Roy, S. C. Gilbert, et al. 2003. Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers. Vaccine 21:1995,
13. McConkey, S. J., W. H. Reece, V. S. Moorthy, D. Webster, S. Dunachie, G. Butcher, J. M. Vuola, T. J. Blanchard, P. Gothard, K. Watkins, et al. 2003. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat. Med. 9:729.
14. + T cells after clearance of hepatitis C virus. J. Immunol. 15:2210.
15. Flanagan, K. L., E. A. Lee, M. B. Gravenor, W. H. Reece, B. C. Urban, T. Doherty, K. A. Bojang, M. Pinder, A. V. Hill, and M. Plebanski. 2001. Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays. J. Immunol. 15:4729.
16. + effector and memory T cell generation. Nat. Immunol. 4:835.
17. Antoine, G., F. Scheiflinger, F. Dorner, and F. G. Falkner. 1998. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 10:365.
18. Laidlaw, S. M., and M. A. Skinner. 2004. Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European fowlpox virus, with those of virulent American and European viruses. J. Gen. Virol. 85:305.
19. + T-cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunisation regimens using a novel attenuated fowlpox virus, J. Immunol. 172:3094.
20. Barouch, D. H., J. Kunstman, M. J. Kuroda, J. E. Schmitz, S. Santra, F. W. Peyeri, G. R. Krivulka, K. Beaudry, M. A. Lifton, D. A. Gorgone, et al. 2002. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415:335.
21. Sinnis, P., and E. Nardin. 2002. Sporozoite antigens: biology and immunology of the circumsporozoite protein and thrombospondin-related anonymous protein. In Malaria Immunology. P. Perlmann and M. Troye-Blomberg, eds. Basel, p. 70.
22. + type 1 responses in humans by a malaria DNA vaccine. Proc. Natl. Acad. Sci. USA 11:10817.
23. + T cell memory. Science 297:2060.